This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGuirk, C. K.
Right arrow Articles by Holmes, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGuirk, C. K.
Right arrow Articles by Holmes, L. B.
Related Collections
Right arrow Infectious Disease & Immunity

PEDIATRICS Vol. 108 No. 4 October 2001, p. e64

ELECTRONIC ARTICLE:
Limb Deficiencies in Newborn Infants

Received Nov 20, 2000; accepted May 29, 2001.

Caroline K. McGuirk*, Marie-Noel WestgateDagger , and Lewis B. Holmes*, Dagger , §

From the * Genetics and Teratology Unit, Pediatric Service, Massachusetts General Hospital, Boston, Massachusetts; the Dagger  Department of Newborn Medicine, Brigham and Women's Hospital, Boston, Massachusetts; and the § Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.

Objective.  The prevalence rate of all types of limb reduction defects in general and those that potentially are caused by vascular disruption in particular is needed to provide a baseline for the evaluation of infants who are exposed in utero to teratogens that cause vascular disruption. The objective of this study was to determine this prevalence rate.

Methods.  All infants with any limb deficiency among 161 252 liveborn and stillborn infants and elective terminations were identified in a hospital-based Active Malformations Surveillance Program in Boston in the years 1972 to 1974 and 1979 to 1994. An extensive search was made to identify infants who were missed by the Surveillance Program; an additional 8 infants (7.3% of total) were identified. The limb reduction defects were classified in 3 ways: 1) by the anatomic location of the defect, that is longitudinal, terminal, intercalary, etc; 2) for infants with absence/hypoplasia of fingers or toes, a tabulation of which digit or digits were affected; and 3) by apparent cause.

Results.  The prevalence rate for all types of limb deficiency was 0.69/1000. The apparent causes included single mutant genes, familial occurrence, and known syndromes (24%); chromosome abnormalities (6%); teratogens (4%); vascular disruption (35%); and unknown cause (32%).

Conclusions.  A hospital-based surveillance program can be used to establish the prevalence of limb reduction defects, if ascertainment is extended to include elective terminations for fetal abnormalities. An apparent cause can be established for most limb defects when the clinical findings are used rather than reliance only on the International Classification of Diseases, Ninth Revision, codes of the discharge diagnoses. The prevalence rate of limb reduction defects as a result of presumed vascular disruption was 0.22/1000.  Key words:  limb deficiency, vascular disruption.




This article has been cited by other articles:


Home page
 Obstet GynecolHome page
A. J. Peller, M.-N. Westgate, and L. B. Holmes
Trends in Congenital Malformations, 1974-1999: Effect of Prenatal Diagnosis and Elective Termination
Obstet. Gynecol., November 1, 2004; 104(5): 957 - 964.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. J. Edison and M. Muenke
Central Nervous System and Limb Anomalies in Case Reports of First-Trimester Statin Exposure
N. Engl. J. Med., April 8, 2004; 350(15): 1579 - 1582.
[Full Text] [PDF]